TICKVALE
>⌘K
NYSE · CIK 0000731766 · HOSPITAL & MEDICAL SERVICE PLANS

UnitedHealth Group Incorporated

UNH chart by TradingView
P/E 20.4xP/B 2.4xP/SALES 0.5xEV/EBITDA 12.8xFCF YIELD 7.99%

PRICE HISTORY

LIVE · NYSE
UNH chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$448B
EBITDA
$23.3B
FREE CASH FLOW
$16.1B
EPS
$13.23
GROSS MARGIN
88.68%
ROIC
7.82%
Q1 FY26ENDED MAR 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

20.4x
-7%
LATEST · Q1 FY26
20.4xQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
13.3x38.0x

P / SALES (TTM)

0.5x
-29%
LATEST · Q1 FY26
0.5xQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
0.5x1.7x

P / BOOK

2.4x
-37%
LATEST · Q1 FY26
2.4xQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
2.4x6.4x

EV / EBITDA (TTM)

12.8x
+8%
LATEST · Q1 FY26
12.8xQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
9.6x18.6x

EV / REVENUE (TTM)

0.7x
-28%
LATEST · Q1 FY26
0.7xQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
0.7x1.8x

FCF YIELD (TTM)

7.99%
+1.6pp
LATEST · Q1 FY26
7.99%Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
1.31%9.59%

DIVIDEND YIELD (TTM)

-0.2pp
LATEST · Q1 FY26
Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
1.28%1.61%

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$112B
+140%
LATEST · Q1 FY26
112BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

EBITDA (DERIVED)

$10.0B
+170%
LATEST · Q1 FY26
10.0BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

NET INCOME

$6.3B
+258%
LATEST · Q1 FY26
6.3BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

EPS (DILUTED)

$6.90
+280%
LATEST · Q1 FY26
6.90Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

REVENUE GROWTH YOY

1.96%
-26.2pp
LATEST · Q1 FY26
1.96%Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
1.96%28.19%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

7.29%
+4.5pp
LATEST · Q1 FY26
7.29%Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
-6.52%22.04%

RETURN ON CAPITAL

7.83%
-2.3pp
LATEST · Q1 FY26
7.83%Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
7.82%22.11%

RETURN ON EQUITY (TTM)

11.59%
-5.4pp
LATEST · Q1 FY26
11.59%Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
11.59%25.71%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN88.52%
OPERATING MARGIN8.05%
NET MARGIN5.62%
FCF MARGIN7.29%
99.6170.6641.7212.77-16.17GROSSOPERNETFCFQ2 FY16Q2 FY17Q2 FY18Q2 FY19Q2 FY20Q2 FY21Q2 FY22Q2 FY23Q2 FY24Q2 FY25Q1 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

$8.1B
+529%
LATEST · Q1 FY26
8.1BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

STOCK-BASED COMP

$0.3B
+231%
LATEST · Q1 FY26
0.3BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

CAPITAL EXPENDITURE

$0.8B
+97%
LATEST · Q1 FY26
0.8BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

SHARES OUTSTANDING

0.91B
-6%
LATEST · Q1 FY26
0.91BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

DIVIDEND / SHARE

+44%
LATEST · Q1 FY26
Q2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

$28.0B
+241%
LATEST · Q1 FY26
28.0BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

TOTAL DEBT

$77.9B
+135%
LATEST · Q1 FY26
77.9BQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26

DEBT / EBITDA (TTM)

3.4x
+38%
LATEST · Q1 FY26
3.4xQ2 FY16Q2 FY18Q2 FY20Q2 FY22Q2 FY24Q1 FY26
1.6x3.4x

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 87.24%INSIDERS 0.24%OTHER / RETAIL 12.52%4,250 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
Blackrock Inc.8.09%73.5M$29.91B-1.7%
Vanguard Capital Management LLC6.48%58.9M$23.97BNEW
State Street Corporation4.99%45.3M$18.45B+0.2%
Capital World Investors3.06%27.8M$11.31B+23.0%
Vanguard Portfolio Management LLC2.65%24.0M$9.78BNEW
Geode Capital Management, LLC2.51%22.8M$9.27B+4.5%
Price (T.Rowe) Associates Inc2.30%20.9M$8.50B+10.9%
Charles Schwab Investment Management, Inc.2.29%20.8M$8.47B+146.6%
JPMORGAN CHASE & CO2.10%19.1M$7.78B+11.1%
Capital Research Global Investors1.88%17.1M$6.97B+173.3%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.